作者: D. Paul Harkin , Daniel B. Longley , John Boyer , Tariq Latif , Pamela Maxwell
DOI:
关键词: Cyclin A 、 Cyclin-dependent kinase 2 、 Cisplatin 、 Cyclin-dependent kinase 、 Biology 、 Biochemistry 、 Cyclin E 、 Thymidylate synthase 、 Camptothecin 、 Cell cycle 、 Cancer research
摘要: Thymidylate synthase (TS) is responsible for the de novo synthesis of thymidylate, which required DNA and repair an important target fluoropyrimidines such as 5-fluorouracil (5-FU), antifolates Tomudex (TDX), ZD9331, multitargeted antifolate (MTA). To study importance TS expression in determining resistance to these agents, we have developed MDA435 breast cancer-derived cell line with tetracycline-regulated termed MTS-5. We demonstrated that inducible increased IC 50 dose TS-targeted therapeutic agents 5-FU, TDX, ZD9331 by 2-, 9- 24-fold respectively. An MTA was unobtainable when overexpressed cells, indicated toxicity highly sensitive levels. The growth inhibitory effects chemotherapeutic CPT-11, cisplatin, oxaliplatin, Taxol were unaffected up-regulation. Cell cycle analyses revealed doses TDX caused S-phase arrest cells did not overexpress TS, this overcome up-regulated. Furthermore, accompanied 2- 4-fold regulatory genes cyclin E , A dependent kinase 2 ( cdk2 ). These results indicate acute increases levels play a key role cellular sensitivity TS-directed drugs modulating degree agents. Moreover, remain cytotoxic TS.